PATENT CLAIM ANALYSIS

Application Number: 15896517
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["536", "023100"]

Abstract:
The present invention relates to an isolated DNA molecule encoding a fagopyritol synthase. A method for producing a fagopyritol, an insulin mediator, an insulin mediator analogue, an insulin mediator homologue, or an insulin mediator inhibitor is also described. The method includes providing a fagopyritol synthase, providing a substrate comprising a galactosyl donor and a galactosyl acceptor, and combining the fagopyritol synthase with the substrate under conditions effective produce a fagopyritol, an insulin mediator, an insulin mediator analogue, an insulin mediator homologue, or an insulin mediator inhibitor.

Claim (Index 62):
The method according to  claim 56 , wherein the galactosyl donor is UDP-galactose.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 88.0
- Lexical Diversity: 2.30233
- Patent Class: 536.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15194232', '15194221', '15194129', '10435226', '14104788']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8663358651316153
- 35 USC 102 Novelty (BERT): 0.7582727801712775
- Combined Prediction Score: 0.8555295566355815
- Mean Citation Score: 1045.69528
- Max Citation Score: 1068.4979
- Similarity Product: 886.5493864019037

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test